Maria Cotaina retweetledi

Happy to share our comprehensive review on MiT-RCC — now published in @Cancers_MDPI!
🔗 doi.org/10.3390/cancer…
TFE3/TFEB-driven kidney cancers are rare but increasingly treatable. We review the molecular biology, modern diagnostics, and emerging evidence for ICI + VEGFR-TKI combinations in metastatic tRCC.
Key takeaway: fusion partner identity shapes both prognosis and treatment response. Precision matters.
Thanks to the whole team — @MarioBalsaMD @OncoSantPau @ICO_oncologia
@myESMO @_SEOM @OncoAlert @Uromigos @IKCCorg @RenalCancerNews
English





















